- cafead   Feb 10, 2025 at 10:12: AM
via Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 trial of its lead drug for idiopathic pulmonary fibrosis (IPF) after seeing a safety signal.
article source
article source